Anzeige
Mehr »
Login
Freitag, 16.04.2021 Börsentäglich über 12.000 News von 660 internationalen Medien
Codename: Siebzehntausend! Rritual landet den "Super-Vertrag"!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1XE3E ISIN: IE00BJYS1G50 Ticker-Symbol: N/A 
1-Jahres-Chart
MAINSTAY MEDICAL INTERNATIONAL PLC Chart 1 Jahr
5-Tage-Chart
MAINSTAY MEDICAL INTERNATIONAL PLC 5-Tage-Chart

Aktuelle News zur MAINSTAY MEDICAL

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MAINSTAY MEDICAL Aktie jetzt für 0€ handeln
09.03.Mainstay Medical Holdings plc: Mainstay Medical gibt Markteinführung von ReActiv8 in Australien bekannt235Mainstay Medical Holdings plc ("Mainstay" oder das "Unternehmen") gab heute die Markteinführung von ReActiv8, dem implantierbaren Neurostimulationssystem zur Behandlung chronischer Schmerzen des unteren...
► Artikel lesen
08.03.Mainstay Medical Holdings plc: Mainstay Medical Announces Commercial Launch of ReActiv8 in Australia179Mainstay Medical Holdings plc ("Mainstay" or the "Company") today announced the commercial launch in Australia of ReActiv8, its implantable neurostimulation system to treat chronic low back pain. ...
► Artikel lesen
17.02.Mainstay Medical raises $108M2
16.02.Mainstay Medical Holdings plc: Mainstay Medical kündigt Transaktion zur Eigenkapitalfinanzierung in Höhe von 108 Millionen US-Dollar an215Mittel sollen die Markteinführung in den USA und weltweite Expansion fördern Mainstay Medical Holdings plc ("Mainstay" oder das "Unternehmen") hat heute den Abschluss einer Eigenkapitalfinanzierung...
► Artikel lesen
16.02.Mainstay Medical Receives US$108M Equity Financing1
16.02.Back pain device group Mainstay Medical raises $108m2
16.02.Mainstay Medical Holdings plc: Mainstay Medical Announces US$108 Million Equity Financing Transaction211Funding to support U.S. commercial launch and global expansion Mainstay Medical Holdings plc ("Mainstay" or the "Company") today announced the closing of an equity financing in which it raised...
► Artikel lesen
25.01.Mainstay Medical Holdings plc: Mainstay Medical meldet wichtige strategische Neueinstellungen zur Förderung seiner globalen kommerziellen Expansion375Die Berufungen sollen die bevorstehende Markteinführung von ReActiv8 in den USA unterstützen und das weitere Wachstum in Europa und Australien fördern Mainstay Medical Holdings plc ("Mainstay"...
► Artikel lesen
25.01.Mainstay Medical Holdings plc: Mainstay Medical Announces Key Strategic Hires to Drive Global Commercial Expansion281Appointments to support upcoming commercial launch of ReActiv8 in the U.S. and foster further growth in Europe and Australia Mainstay Medical Holdings plc ("Mainstay" or the "Company") today announced...
► Artikel lesen
28.07.20Mainstay Medical to Present at the LifeSci Partners Summer Symposium254Mainstay Medical Holdings plc ("Mainstay" or the "Company") today announced that Jason Hannon, Chief Executive Officer, and Matthew Onaitis, Chief Financial Officer, will present a corporate overview...
► Artikel lesen
22.06.20Mainstay Medical Announces U.S. FDA Approval of ReActiv8 Neurostimulation System for Chronic Low Back Pain379U.S. commercialization expected to begin in the first half of 2021 Continues positive momentum for Mainstay, with increasing commercial footprint in Europe and expected launch in Australia...
► Artikel lesen
08.06.20Mainstay Medical Announces Reimbursement Approval for ReActiv8 in Australia227Mainstay Medical Holdings plc ("Mainstay" or the "Company"), today announced that ReActiv8, its implantable restorative neurostimulation system to treat disabling Chronic Low Back Pain, has been approved...
► Artikel lesen
05.06.20Mainstay Medical announces Scheme becoming effective330Not for distribution, directly or indirectly, in the United States of America, Canada, Australia or Japan This announcement is for information purposes only and does not constitute an offer...
► Artikel lesen
04.06.20Mainstay Medical: Receipt of High Court Approval in Connection With Proposed Reorganisation388Not for distribution, directly or indirectly, in the United States of America, Canada, Australia or Japan This announcement is for information purposes only and does not constitute an offer...
► Artikel lesen
03.06.20Mainstay Medical International plc: Total Voting Rights333Regulatory News: Mainstay Medical International plc ("Mainstay" or the "Company") Total Voting Rights In conformity with Regulation 20 of the Transparency (Directive 2004/109/EC)...
► Artikel lesen
01.06.20Mainstay Medical Announces Expected Timetable for Completion of Reorganisation376Not for distribution, directly or indirectly, in the United States of America, Canada, Australia or Japan This announcement is for information purposes only and does not constitute an offer...
► Artikel lesen
25.05.20Mainstay Medical Announces Date for Court Hearing391Not for distribution, directly or indirectly, in the United States of America, Canada, Australia or Japan This announcement is for information purposes only and does not constitute an offer...
► Artikel lesen
08.05.20Mainstay Medical Announces Results of Scheme Meeting and EGM371Not for distribution, directly or indirectly, in the United States of America, Canada, Australia or Japan This announcement is for information purposes only and does not constitute an offer...
► Artikel lesen
18 Nachrichten in den letzten 12 Monaten